Last Updated: July 28, 2026

Claims for Patent: 7,482,015

✉ Email this page to a colleague

Summary for Patent: 7,482,015

Title:	Optimized expression of HPV 45 L1 in yeast
Abstract:	Synthetic DNA molecules encoding the HPV45 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV45 L1 protein, wherein said polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV45 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV45 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.
Inventor(s):	Janine T. Bryan, Michelle K. Brownlow, Loren D. Schultz, Kathrin U. Jansen
Assignee:	Merck Sharp and Dohme LLC
Application Number:	US11/805,453

Details for Patent 7,482,015

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Llc	GARDASIL 9	human papillomavirus 9-valent vaccine, recombinant	Injection	125508	December 10, 2014	7,482,015	2027-05-23
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 7,482,015

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	200601961	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2005032586	⤷ Start Trial
United States of America	2006240040	⤷ Start Trial
United States of America	2008138361	⤷ Start Trial
United States of America	7250170	⤷ Start Trial
Taiwan	200521233	⤷ Start Trial
Taiwan	I350853	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.